New Year Bumper Sale @ Rs. 1 X
Upketo K5 is an allopathic medicine The correct dosage of Upketo K5 depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Upketo K5 is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Upketo K5 safe for pregnant women?
Upketo K5 may cause moderate side effects during pregnancy. If you feel its harmful effects, then stop taking this drug immediately, and do not take Upketo K5 again without your doctor's advice.
Is the use of Upketo K5 safe during breastfeeding?
Information about safety of Upketo K5 for women who are breastfeeding is not available since scientific research on this is yet to be done.
What is the effect of Upketo K5 on the Kidneys?
Upketo K5 may cause harmful effects on kidney. if you feel its having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Upketo K5 on the Liver?
Upketo K5 may cause harmful effects on liver. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Upketo K5 on the Heart?
Very few cases of side effects of Upketo K5 on the heart have been reported.
Upketo K5 should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Upketo K5 unless your doctor advises you to do so -
Is this Upketo K5 habit forming or addictive?
Upketo K5 is not addictive in nature.
Interaction between Food and Upketo K5
Taking Upketo K5 with food does not harm your health.
Interaction between Alcohol and Upketo K5
Information about the interaction of Upketo K5 and alcohol is not currently available because this topic has not been researched yet.
Application of Upketo K5 on the face must be avoided but if it has been advised by your doctor then you can use it only for a short-term period not more than 5 days because the skin on your face thins easily.
No, Upketo K5 alone should not be used for ringworm because it is a fungal infection of the skin caused by fungi such as Trichophyton rubrum and Epidermophyton floccosum and Upketo K5 is not an antifungal agent and it is not effective against fungi. Hence Upketo K5 should not be used for the treatment of ringworm. For the treatment of ringworm, you can use a combination of Upketo K5 and antifungal drugs such as miconazole and fluconazole.
Upketo K5 is a brand name of clobetasol and it comes in the form of ointment, cream, and lotion. It belongs to the class of drug known as steroids (corticosteroids). It is a prescription drug used for the treatment of skin diseases such as corticosteroid-responsive dermatoses, scalp psoriasis, and plaque psoriasis.
Yes, Upketo K5 might cause hair loss (alopecia). It is a rare side effect of this drug and the exact cause behind hair loss is unknown. For partial hair loss, you are advised to use hair solution such as minoxidil.
Upketo K5 is used for the short-term treatment up to 2 weeks and if required then maximum up to 4 weeks. You are advised to use it as directed by your doctor. Do not use this medicine longer than prescribed by your doctor to avoid the unpleasant side effect.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Impoyz (clobetasol propionate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 895
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 369-370
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 136-139
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 750
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Neo-Fradin (neomycin sulfate)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Nizoral (ketoconazole)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 792-793
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 174-177
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 174-176
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 796